Correlation of renin angiotensin and aldosterone system activity with subcutaneous and visceral adiposity: The framingham heart study

BMC Endocrine Disorders

Volumn 12, Issue , 2012, Pages

  O'Seaghdha, Conall M ^a,b,c   Hwang, Shih Jen ^a,b   Vasan, Ramachandran S ^a   Larson, Martin G ^a,d,e   Hoffmann, Udo ^f   Wang, Thomas J ^a,f   Fox, Caroline S ^a,b,c  

^a FRAMINGHAM HEART STUDY   (United States)

^b Center for Population Studies   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Boston University   (United States)

^e BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; RENIN;

ADULT; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE RENIN RATIO; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; OBESITY; PLASMA RENIN ACTIVITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SUBCUTANEOUS FAT; SUPINE POSITION; WAIST CIRCUMFERENCE;

EID: 84859166172     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-12-3     Document Type: Article

References (42)

1. Narkiewicz K. Obesity and hypertension-the issue is more complex than we thought. Nephrol Dial Transplant 2006, 21(2):264-267. 10.1093/ndt/gfi290, 16311261.
2. Garrison RJ, Kannel WB, Stokes J, Castelli WP. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med 1987, 16(2):235-251. 10.1016/0091-7435(87)90087-9, 3588564.
3. Leibson CL, Williamson DF, Melton LJ, et al. Temporal trends in BMI among adults with diabetes. Diabetes Care 2001, 24(9):1584-1589. 10.2337/diacare.24.9.1584, 11522703.
4. Kramer H, Luke A, Bidani A, Cao G, Cooper R, McGee D. Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program. Am J Kidney Dis 2005, 46(4):587-594. 10.1053/j.ajkd.2005.06.007, 16183412.
5. Stengel B, Tarver-Carr ME, Powe NR, Eberhardt MS, Brancati FL. Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology 2003, 14(4):479-487.
6. Poirier P, Despres JP. Waist circumference, visceral obesity, and cardiovascular risk. J Cardiopulm Rehabil 2003, 23(3):161-169. 10.1097/00008483-200305000-00001, 12782898.
7. Klein S. The case of visceral fat: argument for the defense. J Clin Invest 2004, 113(11):1530-1532. 419497, 15173878.
8. Brewster UC, Setaro JF, Perazella MA. The renin-angiotensin-aldosterone system: cardiorenal effects and implications for renal and cardiovascular disease states. Am J Med Sci 2003, 326(1):15-24. 10.1097/00000441-200307000-00003, 12861121.
9. Steckelings UM, Rompe F, Kaschina E, Unger T. The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets. Fundam Clin Pharmacol 2009, 23(6):693-703. 10.1111/j.1472-8206.2009.00780.x, 19817870.
10. Frederich RC, Kahn BB, Peach MJ, Flier JS. Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension 1992, 19(4):339-344.
11. Schorr U, Blaschke K, Turan S, Distler A, Sharma AM. Relationship between angiotensinogen, leptin and blood pressure levels in young normotensive men. J Hypertens 1998, 16(10):1475-1480. 10.1097/00004872-199816100-00011, 9814618.
12. Jeon JH, Kim KY, Kim JH, et al. A novel adipokine CTRP1 stimulates aldosterone production. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology 2008, 22(5):1502-1511.
13. Rossi GP, Belfiore A, Bernini G, et al. Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients. J Clin Endocrinol Metab 2008, 93(7):2566-2571. 10.1210/jc.2008-0251, 18445663.
14. Bentley-Lewis R, Adler GK, Perlstein T, et al. Body mass index predicts aldosterone production in normotensive adults on a high-salt diet. J Clin Endocrinol Metab 2007, 92(11):4472-4475. 10.1210/jc.2007-1088, 17726083.
15. Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007, 116(1):39-48. 10.1161/CIRCULATIONAHA.106.675355, 17576866.
16. Dawber TR, Meadors GF, Moore FE. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health 1951, 41(3):279-281. 10.2105/AJPH.41.3.279, 1525365, 14819398.
17. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol 1979, 110(3):281-290.
18. Splansky GL, Corey D, Yang Q, et al. The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol 2007, 165(11):1328-1335. 10.1093/aje/kwm021, 17372189.
19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130(6):461-470.
20. Maurovich-Horvat P, Massaro J, Fox CS, Moselewski F, O'Donnell CJ, Hoffmann U. Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography. Int J Obes (Lond) 2007, 31(3):500-506.
21. Preis SR, Massaro JM, Robins SJ, et al. Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study. Obesity (Silver Spring) 2010, 18(11):2191-2198.
22. Jain SH, Massaro JM, Hoffmann U, et al. Cross-sectional associations between abdominal and thoracic adipose tissue compartments and adiponectin and resistin in the Framingham Heart Study. Diabetes Care 2009, 32(5):903-908. 10.2337/dc08-1733, 2671095, 19223612.
23. Pou KM, Massaro JM, Hoffmann U, et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 2007, 116(11):1234-1241. 10.1161/CIRCULATIONAHA.107.710509, 17709633.
24. Kathiresan S, Larson MG, Benjamin EJ, et al. Clinical and genetic correlates of serum aldosterone in the community: the Framingham Heart Study. Am J Hypertens 2005, 18(5 Pt 1):657-665.
25. Greenfield JR, Samaras K, Jenkins AB, Kelly PJ, Spector TD, Campbell LV. Moderate alcohol consumption, estrogen replacement therapy, and physical activity are associated with increased insulin sensitivity: is abdominal adiposity the mediator?. Diabetes Care 2003, 26(10):2734-2740. 10.2337/diacare.26.10.2734, 14514572.
26. Cassis LA. Fat cell metabolism: insulin, fatty acids, and renin. Curr Hypertens Rep 2000, 2(2):132-138. 10.1007/s11906-000-0072-5, 10981139.
27. Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC, Cassis LA. Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol 2004, 287(4):R943-949. 10.1152/ajpregu.00265.2004, 15191907.
28. Gupte M, Boustany-Kari CM, Bharadwaj K, et al. ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet. Am J Physiol Regul Integr Comp Physiol 2008, 295(3):R781-788. 10.1152/ajpregu.00183.2008, 2536864, 18650320.
29. Cassis LA, Police SB, Yiannikouris F, Thatcher SE. Local adipose tissue renin-angiotensin system. Curr Hypertens Rep 2008, 10(2):93-98. 10.1007/s11906-008-0019-9, 2702858, 18474174.
30. Thatcher S, Yiannikouris F, Gupte M, Cassis L. The adipose renin-angiotensin system: role in cardiovascular disease. Mol Cell Endocrinol 2009, 302(2):111-117. 10.1016/j.mce.2009.01.019, 2748818, 19418627.
31. Massiera F, Bloch-Faure M, Ceiler D, et al. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J 2001, 15(14):2727-2729.
32. Engeli S, Bohnke J, Gorzelniak K, et al. Weight loss and the renin-angiotensin-aldosterone system. Hypertension 2005, 45(3):356-362. 10.1161/01.HYP.0000154361.47683.d3, 15630041.
33. Chen W, Srinivasan SR, Berenson GS. Plasma renin activity and insulin resistance in African American and white children: the Bogalusa Heart Study. Am J Hypertens 2001, 14(3):212-217. 10.1016/S0895-7061(00)01274-7, 11281231.
34. Lind L, Reneland R, Andersson PE, Haenni A, Lithell H. Insulin resistance in essential hypertension is related to plasma renin activity. J Hum Hypertens 1998, 12(6):379-382. 10.1038/sj.jhh.1000642, 9705039.
35. Haenni A, Reneland R, Lind L, Lithell H. Serum aldosterone changes during hyperinsulinemia are correlated to body mass index and insulin sensitivity in patients with essential hypertension. J Hypertens 2001, 19(1):107-112. 10.1097/00004872-200101000-00014, 11204289.
36. Allikmets K, Parik T, Teesalu R. Association between plasma renin activity and metabolic cardiovascular risk factors in essential hypertension. J Intern Med 1996, 239(1):49-55. 10.1046/j.1365-2796.1996.414756000.x, 8551200.
37. Colussi G, Catena C, Lapenna R, Nadalini E, Chiuch A, Sechi LA. Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients. Diabetes Care 2007, 30(9):2349-2354. 10.2337/dc07-0525, 17575088.
38. Umemura S, Nyui N, Tamura K, et al. Plasma angiotensinogen concentrations in obese patients. Am J Hypertens 1997, 10(6):629-633. 10.1016/S0895-7061(97)00053-8, 9194508.
39. Faloia E, Gatti C, Camilloni MA, et al. Comparison of circulating and local adipose tissue renin-angiotensin system in normotensive and hypertensive obese subjects. J Endocrinol Invest 2002, 25(4):309-314.
40. Gorzelniak K, Engeli S, Janke J, Luft FC, Sharma AM. Hormonal regulation of the human adipose-tissue renin-angiotensin system: relationship to obesity and hypertension. J Hypertens 2002, 20(5):965-973. 10.1097/00004872-200205000-00032, 12011658.
41. Engeli S, Schling P, Gorzelniak K, et al. The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?. Int J Biochem Cell Biol 2003, 35(6):807-825. 10.1016/S1357-2725(02)00311-4, 12676168.
42. James GD, Sealey JE, Muller F, Alderman M, Madhavan S, Laragh JH. Renin relationship to sex, race and age in a normotensive population. J Hypertens Suppl 1986, 4(5):S387-389.